Medicago is a biotechnology company that focuses on developing plant-based therapies and vaccines. Founded in 1999, it uses a unique platform that employs alfalfa plants to produce proteins for medical applications. This method allows for rapid production and scalability, making it a promising approach in the field of biopharmaceuticals. The company gained attention for its work on a COVID-19 vaccine, which demonstrated the potential of its technology in responding to global health challenges. By harnessing the natural processes of plants, Medicago aims to create effective and affordable solutions for various diseases, contributing to advancements in healthcare.